Nuformix PLC (NFX)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.23p

Buy

0.27p

arrow-up0.00p (+0.00%)

Prices updated at 17 Dec 2025, 16:25 GMT

Prices minimum 15 mins delay

Prices in GBX

Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.

FTSE All-Share

0.88%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2022	2024
	50,000	-
	48,305	-
	-1m	-506,353
	-2,540.54	-
	-1m	-4m
	-1m	-477,187
Sales, General and administrative	1m	506,353
Interest expenses	-	-
Provision for income taxes	-161,279	-5,566
Operating expenses	1m	506,353
Income before taxes	-1m	-4m
Net income available to common shareholders	-1m	-4m
	-0.001669	-0.004517
Net interest income	-	-
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-0.001669	-0.004517
Free cash flow per share	-0.0016	-0.0003
Book value/share	0.0064	0.0028
Debt equity ratio	-	-

Balance sheet

Year chevron-l-regular chevron-r-regular	2022	2024
Current assets	824,974	59,127
Current liabilities	237,861	254,967
Total capital	5m	715,571
Total debt	-	-
Total equity	5m	715,571
Total non current liabilities	-	-
Loans	-	-
Total assets	5m	970,538
Total liabilities	-	-
Cash and cash equivalents	464,095	20,210
Common stock	627m	834m

Cash flow

Year chevron-l-regular chevron-r-regular	2022	2024
Cash at beginning of period	2m	202,548
Cash dividends paid	-	-
	-1m	-331,883
Investments (gains) losses	-	-
	464,095	20,210
Net income	-	-
	-1m	-331,883
	-	-

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.